WELCOME TO XBIOTECH
XBiotech is developing True Human Antibodies to provide breakthrough therapies for patients. In 2010 XBiotech made history with the clinical launch of the first true human antibody therapeutic. The Company’s lead therapeutic antibody programs, targeting diseases including cancer, atherosclerosis, transplant rejection and diabetes, represent what we believe to be one of the most important biopharmaceutical development initiatives in the world today.
NEWS
07.28.10
Therapeutic antibody has shipped to Zurich for compassionate use -
At the request of the University Hospital of Zurich, one of Europe’s…more
06.18.10
The next investigational drug application -
is set to launch.
With the submission of an IND (investigational new…more
